Changes in biofilm in chronic cholesteatomatous otitis media in children following the application of sodium 2-mercaptoethanesulfonate (Mesna (cas 19767-45-4))

Add time:09/04/2019    Source:sciencedirect.com

BackgroundPediatric cholesteatoma is a clinically challenging disease entity. Its biological behavior in the pediatric population differs from its behavior in adult population in terms of aggressiveness and recurrence. Several studies have shown the presence of biofilms associated with cholesteatoma that hinder the management and eradication of the infection. This led is to study the use of non-antimicrobial treatments impacting on the structure or composition of biofilms.

We also recommend Trading Suppliers and Manufacturers of Mesna (cas 19767-45-4). Pls Click Website Link as below: cas 19767-45-4 suppliers

Prev:Original articleMesna (cas 19767-45-4) (2-mercaptoethane sodium sulfonate) functions as a regulator of myeloperoxidase☆
Next:Mesna (cas 19767-45-4))